He also hosts his podcast Startup Confidential
Research presented at the ACR Convergence 2025 conference showed that RA patients with elevated BMI who took GLP-1 receptor agonists experienced superior improvements in disease activity scores, pain levels, and weight loss compared to controls
For weight management, Zepbound is indicated for adults with a BMI 30 kg/m (obesity) or 27 kg/m (overweight) with at least one weight-related comorbidity
Alrededor del 40% de los adultos en los Estados Unidos tienen obesidad, con un ndice de masa corporal (IMC) de 30 o ms
This includes reviewing medical history, current medications, and potential drug interactions
In a Phase I clinical trial, a PYY analog named Y14 peptide was administered subcutaneously every 7 to 14 days